SCHEMBL28518784

SCHEMBL28518784

C=C(Cc1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 19/20 0.70
RXRG P48443 9/20 0.70
RXRB P28702 8/20 0.70
RARB P10826 6/20 0.70
RARG P13631 5/20 0.70
RARA P10276 3/20 0.70
CYP26A1 O43174 2/20 0.70
CYP26B1 Q9NR63 2/20 0.70
MEN1 O00255 1/20 0.70
ABCB11 O95342 1/20 0.70
ESR1 P03372 1/20 0.70
PGR P06401 1/20 0.70
HTR1A P08908 1/20 0.70
ADRA2A P08913 1/20 0.70
ADORA3 P0DMS8 1/20 0.70
CHRM1 P11229 1/20 0.70
DRD1 P21728 1/20 0.70
TBXA2R P21731 1/20 0.70
SLC6A2 P23975 1/20 0.70
ADRA1A P35348 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28907614 0.87 RXRA (0.68) RXRARXRGRXRBRARBRARG
SCHEMBL7243713 0.84 RXRA (0.68) RXRARXRGRXRBRARBRARG
Bexarotene SCHEMBL5322954 0.82 RXRA (1.00) RXRARXRGRXRBRARBRARG
Bexarotene SCHEMBL9025 0.82 RXRA (1.00) RXRARXRGRXRBRARBRARG
Bexarotene SCHEMBL29412584 0.82 RXRA (1.00) RXRARXRGRXRBRARBRARG
SCHEMBL3980286 0.82 RXRA (0.74) RXRARXRGRXRBRARBRARG
SCHEMBL8320253 0.81 RXRA (0.58) RXRARXRGRXRBRARBRARG
Bexarotene SCHEMBL4432606 0.81 RXRA (0.97) RXRARXRGRXRBRARBRARG
SCHEMBL8318880 0.81 RXRA (0.57) RXRARXRGRXRBRARBRARG
SCHEMBL28518208 0.80 HNF4A (0.57) RXRARXRGRXRBRARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112218629-A Bexarotene derivatives and their use in the treatment of cancer DJ疗法有限责任公司 2021-01-12 CN disclosed